Hailir’s thiamethoxam, chlorantraniliprole technical registered in Australia

In March 2023, a notification of the Australian APVMA revealed the granting of registrations to Hailir’s thiamethoxam and chlorantraniliprole technical.

Coupled with the previous 13 registrations in Australia, Hailir finds itself in a solid position to develop the Australian market, as supported by its production and supply capacity.

Hailir’s previous registrations in Australia include emamectin benzoate 95% TC, difenoconazole 96 TC, clothianidin 97% TC, pinoxaden 97% TC, chlorantraniliprole 96% TC, thiamethoxam 98% TC, fipronil 97% TC, acetamiprid 99% TC, diafenthiuron 96% TC, glufosinate 95% TC, prothioconazole 98% TC, pyraclostrobin 98% TC and imidacloprid 98% TC.

Hailir is one of China’s leading neonicotine pesticide manufacturers, with a production capacity ranked among the country’s top three. The company’s second-generation nicotine capacity, covering thiamethoxam and clothianidin, reaches 3,000 tons, which is backed up by its own supply of raw materials, thus ensuring the company’s stable production and cost advantage.

In recent years, Hailir has been aggressively promoting its overseas business layout and has achieved increases in the market share of Pakistan, India, Turkey and Russia. Meanwhile, the business relationship with multinationals is being constantly reinforced, with significant breakthroughs achieved regarding cooperation with customers in Brazil, Germany, France, Australia and Israel.

For developing new markets, Hailir has continued its market exploration and has established branches or subsidiaries in Brazil, Argentina, the Philippines, Myanmar, and Laos.

While supporting customer registration, Hailir has conducted independent registrations in Europe, the United States, Canada, Australia and New Zealand. Today, Hailir’s international business presence has extended to 80 countries and regions, with more than 3,000 products having been registered.